A detailed history of Vanguard Group Inc transactions in Evoke Pharma Inc stock. As of the latest transaction made, Vanguard Group Inc holds 29,851 shares of EVOK stock, worth $14,029. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,851
Previous 29,851 -0.0%
Holding current value
$14,029
Previous $18,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.95 - $3.43 $2,895 - $5,093
-1,485 Reduced 4.74%
29,851 $56,000
Q2 2022

Aug 12, 2022

BUY
$2.04 - $10.32 $63,925 - $323,387
31,336 New
31,336 $102,000

Others Institutions Holding EVOK

About Evoke Pharma Inc


  • Ticker EVOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,343,070
  • Market Cap $1.57M
  • Description
  • Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...
More about EVOK
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.